ERD

Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

COATED ONCOLYTIC ADENOVIRUSES FOR CANCER VACCINES

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantig...

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Design and application of oncolytic viruses for cancer immunotherapy

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Artificially cloaked viral nanovaccine for cancer immunotherapy

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Periodic Reporting for period 4 - PeptiCrad (Personalized oncolytic vaccines for cancer immunotherapy)

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Matu...

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Pathogens: Our Allies against Cancer?

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

COATED ONCOLYTIC ADENOVIRUSES FOR CANCER VACCINES

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity.

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector p...

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Patient-Derived Organoids for Precision Cancer Immunotherapy

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

COATED ONCOLYTIC ADENOVIRUSES FOR CANCER VACCINES

Project: PeptiCrad

Updated at: 27-04-2024

Show more information

Project acronym PeptiCrad

Resources

Selected filters:

Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

COATED ONCOLYTIC ADENOVIRUSES FOR CANCER VACCINES

Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantig...

Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy

Design and application of oncolytic viruses for cancer immunotherapy

Artificially cloaked viral nanovaccine for cancer immunotherapy

Periodic Reporting for period 4 - PeptiCrad (Personalized oncolytic vaccines for cancer immunotherapy)

β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Matu...

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity

Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment

Pathogens: Our Allies against Cancer?

COATED ONCOLYTIC ADENOVIRUSES FOR CANCER VACCINES

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification

Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity.

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector p...

GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy

Patient-Derived Organoids for Precision Cancer Immunotherapy

COATED ONCOLYTIC ADENOVIRUSES FOR CANCER VACCINES